Category | Qualitative answers# | Frequency n (%) |
Clinical course | ||
Clinical judgement | Clinical improvement (clinical judgement or not specified) | 36 (37.1) |
Oral intake | Able to swallow, no nausea, vomiting or diarrhoea | 20 (20.6) |
Temperature | Fever subsiding | 19 (19.6) |
No fever | 36 (37.1) | |
No fever for ≥1 day | 7 (7.2) | |
No fever for ≥2 days | 6 (6.2) | |
Other | 1 (1.0) | |
Respiratory | Dyspnoea subsiding | 16 (16.5) |
Less/no need for oxygen administration | 24 (24.7) | |
Cardiovascular | Haemodynamically stable | 21 (21.6) |
No signs of sepsis | 4 (4.1) | |
Other | 16 (16.5) | |
Patient characteristics | ||
Subjective | Patient feels better | 16 (16.5) |
Other | 1 (1.0) | |
Laboratory parameters | ||
Inflammation parameters | Decrease in C-reactive protein | 47 (48.4) |
Decrease in leukocytes | 12 (12.4) | |
Other | 2 (2.0) | |
Culture | Pathogen known/culture results available | 11 (11.3) |
Practical considerations | ||
Timeline | i.v. antibiotics, at least until day 2 | 4 (4.1) |
i.v. antibiotics, at least until day 3 | 17 (17.5) | |
i.v. antibiotics, at least until day 4 | 16 (16.5) | |
Other | 3 (3.1) | |
Choice of antibiotics | A good oral variant is available | 6 (6.2) |
Other | 5 (5.1) |
#: answers are displayed in detail if they were provided by ≥4 physicians.